Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

PMID:
25051258
[PubMed - in process]
Free PMC Article
2.

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C; RE-COVER II Trial Investigators.

Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16.

PMID:
24344086
[PubMed - indexed for MEDLINE]
3.

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators.

Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2.

PMID:
23999456
[PubMed - indexed for MEDLINE]
4.

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.

Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators.

JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. Erratum in: JAMA. 2013 Apr 10;309(14):1461.

PMID:
23478743
[PubMed - indexed for MEDLINE]
5.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

PMID:
23425163
[PubMed - indexed for MEDLINE]
Free Article
6.

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators.

N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.

PMID:
23388003
[PubMed - indexed for MEDLINE]
Free Article
7.

Prevalence of metabolic syndrome, insulin resistance, and microvascular angina pectoris in 500 consecutive patients referred to coronarography.

Hrnciar J, Avdicova M, Gabor D, Hrnciarova M, Chamulova M, Jakubikova K, Kaliska G, Kikova V, Kovar F, Kreze A Jr, Lepej J, Okapcova J, Szentivanyi M.

Endocr Regul. 2013 Jan;47(1):33-8.

PMID:
23363255
[PubMed - indexed for MEDLINE]
8.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

PMID:
23121378
[PubMed - indexed for MEDLINE]
Free Article
9.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

PMID:
22570699
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group.

N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598. Epub .

PMID:
19966341
[PubMed - indexed for MEDLINE]
Free Article
11.

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Brugts JJ, de Maat MP, Boersma E, Witteman JC, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AH, Simoons ML; EUROPA-PERGENE investigators.

Cardiovasc Drugs Ther. 2009 Apr;23(2):171-81. doi: 10.1007/s10557-008-6156-1. Epub 2008 Dec 10.

PMID:
19082699
[PubMed - indexed for MEDLINE]
12.

Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II.

Szentiványi M Jr, Zou AP, Mattson DL, Soares P, Moreno C, Roman RJ, Cowley AW Jr.

Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R266-72.

PMID:
12069953
[PubMed - indexed for MEDLINE]
13.

[Thallium scintigraphy of the myocardium in evaluation of patients with insulin resistance syndrome and microvascular angina pectoris].

Lepej J, Spisiaková D, Hrnciar J, Okapcová J, Szentivanyi M, Kurray P.

Vnitr Lek. 2000 Apr;46(4):205-12. Slovak.

PMID:
11227172
[PubMed - indexed for MEDLINE]
14.

Nitric oxide in the renal medulla protects from vasopressin-induced hypertension.

Szentiványi M Jr, Park F, Maeda CY, Cowley AW Jr.

Hypertension. 2000 Mar;35(3):740-5.

PMID:
10720588
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of combined sex hormone replacement therapy on small artery biomechanics in pharmacologically ovariectomized rats.

Acs N, Székács B, Nádasy GL, Várbíró S, Miklós Z, Szentiványi M Jr, Monos E.

Maturitas. 2000 Jan 15;34(1):83-92.

PMID:
10687886
[PubMed - indexed for MEDLINE]
16.

Increase in renal medullary nitric oxide synthase activity protects from norepinephrine-induced hypertension.

Szentiványi M Jr, Zou AP, Maeda CY, Mattson DL, Cowley AW Jr.

Hypertension. 2000 Jan;35(1 Pt 2):418-23.

PMID:
10642335
[PubMed - indexed for MEDLINE]
Free Article
17.

[Management of ventricular tachycardia after acute myocardial infarct].

Kaliska G, Alberty R, Kmec P, Szentivanyi M.

Bratisl Lek Listy. 1999 Jul;100(7):371-8. Slovak.

PMID:
10622115
[PubMed - indexed for MEDLINE]
18.

[Radiofrequency ablation of type I atrial flutter. Personal experience].

Szentiványi M, Kaliská G.

Vnitr Lek. 1999 Jan;45(1):35-9. Slovak.

PMID:
10422524
[PubMed - indexed for MEDLINE]
19.

[Risk factors and prevention of sudden cardiac death in patients with ventricular tachycardia after myocardial infarct].

Kaliská G, Szentiványi M, Kmec P, Alberty R.

Vnitr Lek. 1999 Jan;45(1):22-9. Slovak.

PMID:
10422522
[PubMed - indexed for MEDLINE]
20.

[Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes].

Hrnciar J, Gábor D, Hrnciarová M, Okapcová J, Szentiványi M, Kurray P.

Vnitr Lek. 1999 Jan;45(1):11-6. Slovak.

PMID:
10422520
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk